April 2025 PMID 39701869

Randomized controlled trials - The what, when, how and why.

Luis H Braga, Forough Farrokhyar, M İrfan Dönmez, Caleb P Nelson, Bernhard Haid, Kathy Herbst, Massimo Garriboli, Salvatore Cascio, Anka Nieuwhof-Leppink, Martin Kaefer, Darius J Bägli, Nicholas Kalfa, Christina Ching, Magdalena Fossum, Luke Harper

Mentions

16
Peak: 1 in May 2025
across 4 sources since May 2025

Extended reach

43,114
potential audience

Total likes

603

Video views

10,824

Mentions per month

May 2025 – Oct 2025

Where it's discussed

  • News11 articles
  • YouTube2 videos
  • Blogs2 articles
  • X / Twitter1 posts

AI synopsis

What people are saying

The collective discussions reflect an overall cautious yet curious perspective, exemplified by comments questioning the interpretation of the publication's message, such as 'that's not what AI is telling me,' indicating a degree of skepticism or differing interpretations. The tone is informal and somewhat skeptical, which tempers the perceived influence of the shared article, emphasizing the need for nuanced understanding and critical engagement.

AgreementModerate agreement

The initial post questions the validity of the publication based on AI insights, indicating some skepticism but not outright rejection.

InterestModerate interest

The discussion shows moderate engagement with the topic, referencing the article and related works, suggesting a genuine curiosity.

EngagementNeutral engagement

The engagement is minimal, with only a brief critique rather than in-depth analysis or debate.

ImpactModerate impact

The post hints at potential implications of AI's role in interpreting RCTs, which could influence future discussions but remains quite cautious.

Abstract in brief

  • RCTs are considered the gold standard for evaluating new treatments due to their random allocation of participants and design features that minimize bias.
  • The review emphasizes parallel group RCTs in Pediatric Urology, detailing the process from pilot studies to the main trial, while recognizing that poor design elements can lead to misleading outcomes.
  • Despite their advantages, RCTs may not be suitable for all surgical questions due to cost and feasibility issues, highlighting the need for careful interpretation of evidence from various study designs.

Top posts

Most liked on X and Bluesky
Ash Paul
@pash22 · X

@metapredict @BartosFra That's not what AI is telling me. "Randomized controlled trials: The what, when, how and why" https://t.co/rEHZVg5B0l via @LuisHPBraga et al https://t.co/X7ybJDpQQN

May 31, 2025 · 1 like · 32,290 followers View post →

All mentions

Ash Paul
@pash22 · X

@metapredict @BartosFra That's not what AI is telling me. "Randomized controlled trials: The what, when, how and why" https://t.co/rEHZVg5B0l via @LuisHPBraga et al https://t.co/X7ybJDpQQN

May 31, 2025 · 1 like · 32,290 followers View post →